论文信息 - Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts. - 字舞流文

Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts.

H. Ishitsuka | N. Sawada | T. Ishikawa | Y. Fukase | M. Nishida | T Ishikawa | M Utoh | N Sawada | M Nishida | Y Fukase | F Sekiguchi | H Ishitsuka | M. Utoh | F. Sekiguchi | Miwa Nishida

[1] C. Presant,et al. Association of intratumoral pharmacokinetics of fluorouracil with clinical response , 1994, The Lancet.

[2] R. Diasio,et al. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. , 1987, Cancer research.

[3] H. Ishitsuka,et al. Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells. , 1986, Chemical & pharmaceutical bulletin.

[4] F N Naguib,et al. Enzymes of uracil catabolism in normal and neoplastic human tissues. , 1985, Cancer research.

[5] H. Ishitsuka,et al. Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. , 1983, Chemical & pharmaceutical bulletin.

[6] C. Heidelberger,et al. Biochemical characterization of fluoropyrimidine-resistant murine leukemic cell lines. , 1982, Cancer research.

[7] R. Glazer,et al. Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil. , 1980, Cancer research.

[8] P. Reyes,et al. Synthesis of 5-fluorouridine 5'-phosphate by a pyrimidine phosphoribosyltransferase of mammalian origin. II. Correlation between the tumor levels of the enzyme and the 5-fluorouracil-promoted increase in survival of tumor-bearing mice. , 1969, Biochemical pharmacology.